Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Affiliations

• ¹ Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
• ² Department of Hematology-Oncology, Georgetown University, Washington, DC.
• ³ Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA.
• ⁴ Department of Medicine, University of Iowa, Iowa City, IA.
• ⁵ Department of Internal Medicine-Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC.
• ⁶ Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.
• ⁷ Wilmot Cancer Institute, University of Rochester, Rochester, NY.
• ⁸ Lymphoma Program, Washington University School of Medicine Siteman Cancer Center, St. Louis, MO.
• ⁹ HIV/AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD.
• ¹⁰ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.